Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry designates a pseudogene belonging to the zinc finger protein 253 gene family, a group of Krüppel-associated box (KRAB) domain-containing C2H2-type zinc finger transcription factors[7][8]. Pseudogenes arise from duplication or retrotransposition of a functional gene and typically do not code for functional protein products. As such, this pseudogene does not have known physiological or pharmacological roles, is not considered a therapeutic target, and has no known clinical relevance. Additional Notes: - The inclusion of "pseudogene" in the name and the Ensembl identifier indicates it is not a protein-coding nor regulatory RNA gene and is not a valid drug target. - If you meant the functional gene ZNF253, this would refer to a KRAB zinc finger transcription factor, which may have roles in transcriptional repression and cell signaling pathways[7][8], but the pseudogene does not inherit these functions. - This pseudogene may still be of interest for genomic studies or evolutionary biology but is not relevant for therapeutic development nor biomarker research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 253 pseudogene.